Davis Polk advised the placement agents in the transaction. Recursion Pharmaceuticals executed its $150 million private placement of common stock. Morgan Stanley & Co. LLC acted as the...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Denali Therapeutics on the deal, while Davis Polk advised the representatives of the several underwriters. Denali Therapeutics, a biopharmaceutical company...
You must be a Standard 1 Year member to access this content.
Davis Polk represented Jefferies LLC, the sole book-running manager, in the offering. EDAP TMS S.A. executed $23 million public offering of 3,066,667 American Depositary Shares (which includes...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representatives of the underwriters in the offering. Allakos Inc. announced its offering of 29,882,000 shares of common stock, for total gross proceeds of...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented IDEAYA, while Davis Polk advised the representatives of the several underwriters in the offering. IDEAYA Biosciences, Inc. (Nasdaq: IDYA) announced the pricing of an...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Bloom Energy in the transaction, while Davis Polk advised the underwriters. Bloom Energy Corporation (NYSE: BE), the developer of a solid-oxide platform for...
You must be a Standard 1 Year member to access this content.
Freshfields advised CarLotz on the deal. Davis Polk advised the financial advisers. CarLotz, Inc. (Nasdaq: LOTZ), a leading consignment-to-retail used vehicle marketplace, was sold to Shift...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the sales agent in the offering. RxSight, Inc. announced its shares of common stock for up to an aggregate amount of $50 million....
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher advised Intel, while Davis Polk & Wardwell advised the underwriters on the offering. Intel Corporation executed the offering consisting of $1.25 billion aggregate principal...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Allakos, while Davis Polk advised the underwriter, Cowen, in the offering. Allakos Inc. announced it may issue and sell shares of...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Revolution Medicines, while Davis Polk advised the underwriters in the offering. Revolution Medicines, Inc. (Nasdaq: RVMD), has announced the pricing of its underwritten...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the sales agents in the offering. ChargePoint Holdings, Inc. finalized a $500 million SEC-registered at-the-market offering of its common stock. ChargePoint’s common stock is...
You must be a Standard 1 Year member to access this content.
